Antigen retrieval and how does it work
What is antigen retrieval and how does it work? Antigen retrieval is an effective method of unmasking antigenic epitopes on the surface of formalin-fixed paraffin-embedded (FFPE) tissue sections. The antigen retrieval technique breaks the methylene bridges between...
Overview of Immunohistochemistry (IHC)
Overview of Immunohistochemistry (IHC) Diagnostic pathology has exponentially advanced over the last few decades due to the implementation of various novel techniques. The most notable of these techniques for diagnosis is immunohistochemistry (IHC). BioGenex, a...
Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma Differentiation by New miRNA Biomarker Panel
Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma Differentiation by New miRNA Biomarker Panel Ready-to-Use fully optimized SSNA miRNA In Situ Hybridization (ISH) Kit Pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CC) are two highly...
Squamous Cell Carcinoma Differentiation of Cervical Cancer using New miRNA Biomarker Panel
Squamous Cell Carcinoma Differentiation of Cervical Cancer using New miRNA Biomarker Panel Ready-to-Use fully optimized SSNA miRNA In Situ Hybridization (ISH) Kit Cervical cancer is one of the most common malignant tumors of the female reproductive tract. It is the...
Glioma Prognostic Subtyping – Astrocytoma, Oligodendroglioma, Meningioma, and Glioblastoma using New miRNA Biomarker Panel
Glioma Prognostic Subtyping - Astrocytoma, Oligodendroglioma, Meningioma, and Glioblastoma using New miRNA Biomarker Panel Ready-to-Use fully optimized SSNA miRNA In Situ Hybridization (ISH) Kit Malignant gliomas are extremely aggressive and lethal form of brain...
Biomarker Panel for Differentiation of Wild Type and Breast Cancer Susceptibility Gene (BRCA) Mutated Breast Cancer
Biomarker Panel for Differentiation of Wild Type and Breast Cancer Susceptibility Gene (BRCA) Mutated Breast Cancer miRNA SSNA in situ Hybridization System Breast cancer represents a heterogeneous group of tumors characterized by a wide range of clinical, pathologic...
Wild Type and Mutated BRCA – Differentiation of Breast Cancer using New miRNA Biomarker Panel
Wild Type and Mutated BRCA - Differentiation of Breast Cancer using New miRNA Biomarker Panel Ready-to-Use fully optimized SSNA miRNA In Situ Hybridization (ISH) Kit Breast cancer represents a heterogeneous group of tumors characterized by a wide range of clinical,...
Squamous Cell Carcinoma (SCC) and Adenocarcinoma (AD) Differentiation in Non-Small Cell Lung Cancer (NSCLC) using New miRNA Biomarker Panel
Squamous Cell Carcinoma (SCC) and Adenocarcinoma (AD) Differentiation in Non-Small Cell Lung Cancer (NSCLC) using New miRNA Biomarker Panel Ready-to-Use fully optimized SSNA miRNA In Situ Hybridization (ISH) Kit Lung cancer represents a heterogeneous group of tumors...
Triple Negative Breast Cancer – Differentiation of TNBC (ER-, PR-, and HER2/neu-) using New miRNA Biomarker Panel
Triple Negative Breast Cancer - Differentiation of TNBC (ER-, PR-, and HER2/neu-) using New miRNA Biomarker Panel Ready-to-Use fully optimized SSNA miRNA in situ hybridization (ISH) kit Like many cancers, breast cancers are highly diverse with a range of distinct...
Prostate Cancer (PC) and Benign Prostatic Hyperplasia (BPH) Differentiation by New miRNA Biomarker Panel
Prostate Cancer (PC) and Benign Prostatic Hyperplasia (BPH) Differentiation by New miRNA Biomarker Panel Ready-to-Use fully optimized SSNA miRNA In Situ Hybridization (ISH) Kit Prostate cancer and benign prostatic hyperplasia (BPH) are the most frequent and deadly...